Presentation TCT 2013 SYNERGY and the EVOLVE Clinical Trial Program: Minimizing the Abluminal Polymer Load while Accelerating Bioresorption Presenter: Ian Meredith October 27, 2013 REGISTER for free or LOG IN to view this content DES/BRS/DCB Presentation TCT 2013 Up Next Presentation TCT 2013 The Emerging Role of High Sensitivity Troponin Assays- Benefits and Caveats Presenter: Colin Barker October 27, 2013 More slides + Presentation TCT 2013 Stenting Is the First-line Treatment for SFA Disease! Presenter: J. Michael Bacharach October 27, 2013 Presentation TCT 2013 Clinical Applications of CMR Presenter: Stamatios Lerakis October 27, 2013 We Recommend
Presentation TCT 2013 The Emerging Role of High Sensitivity Troponin Assays- Benefits and Caveats Presenter: Colin Barker October 27, 2013
Presentation TCT 2013 Stenting Is the First-line Treatment for SFA Disease! Presenter: J. Michael Bacharach October 27, 2013